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DETERMINATION OF SOME PHYSICAL PARAMETERS OF 
ALTERNATIVE TREATMENT SOLUTIONS IN KERATOCONUS 
 
SUMMARY 
Genetically or enviromentally occurance of Keratoconus illness in human eyes causes  
thinner cornea with lose of transparency. Thinner cornea tends to bulg outward like a 
cone shape. As a result of Keratoconus cornea can not refract the light correctly and 
some eye disorders are occured which can not be suppported by eye glasses. Collagen 
Cross Linking (CXL or CCL)  is suggested in this study to overcome these eye 
disorders. By the application of CXL with proper corneas , firstly cornea gain its 
primer elasticity, curvature of it becomes better and the illness of Keratoconus is 
stopped completely.  
Basicly in collagen crosslinking , a solution with Riboflavin is dropped and a particular 
intensity of UV-A radiation is exposed to the cornea. The light is absorbed by 
Riboflavin and this reaction lets the free oxygen radicals to be generated. This radicals 
cause cross links between nano dimensional fibrilles and collagen cross linking are 
observed through cornea. In the routin treatment, 0,1% Riboflavin and Dextran are 
dissolved in saline solution. Here Riboflavin is a photoreactive chemical and Dextran 
is a high weight polysaccharide works as a preventer for cornea against undesirable 
swelling during treatment. 
Today all over the world, CXL is used as the unique treatment for Keratoconus and it 
is quite succesful to stop the illness, but it has still some insufficiencies and side effects. 
First of all CXL can not be applied thin corneas like having a thickness under 400 µm. 
UV-A radiation may cause chemical burns inside the bottom layers of cornea. Another 
risk is edemas as a result of sudden temperature exchanges on the cornea causing 
degeneration of  DNA structure. Also high temperature can disturb the protein 
structure of cornea and it results as cataract. 
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 In this master thesis, in order to overcome the insufficiencies of the CXL, new 
alternative solutions were proposed and some important physical parameters are 
measured within them. Also the dependence of different Riboflavin concentrations 
with respect to temperature exchange are measured. 0,2% as high concentration and 
0,04% Riboflavin as low concentration are chosen. 
To prepare the new solutions, apart from Dextran which is a polysaccharide having 
many glucose molecules, another polysaccharide called Dextrin was used too. Glucose 
molecule is an important role for nutrition for the cornea. Combining of all this 
materials, eight new solutions were prepared.  
To be able to search the reason of the side effects in the CXL treatment,  some physical 
parameters were investigated in this study. These parameters are temperature exchange 
which was studied with three different temperatures like 24 °C (room temperature), 
34° C (cornea temperature), 41°C (high fever temperature) and compared the results 
of experimental temperature exchanges with theretical ones, pH level exchange before 
and after UV-A radiation, diffusion coefficients which  were determined by the time-
drive measurements  and finally viscosity of the solutions. As it mentioned before, 
sudden temperature exchanges are dangerous for cornea and so it shoul be get under 
control. Moreover any solution which has a pH  level not compatible with cornea, may 
cause acidic or alcali burns. Solutions’ diffusion coefficients are compared with 
respect to their magnitudes, because the greater coefficient let greater penetration of 
solutions with cornea. Finally the viscosity of solutions are measured before and after 
UV-A radiation. By measuring viscosity, the solutions could be analysed as Newtonian 
or Non-Newtonian fluid. Moreover wheter  UV-A radiation cause any change in 
viscosity of solutions could be determined. 
After all physical parameters are measured with all solutions, a most proper alternative 
is suggested for routine CXL treatment. 
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KERATOKONUS’ TA ALTERNATİF TEDAVİ SOLÜSYONLARI İÇİN BAZI 
FİZİKSEL PARAMETRELERİN BELİRLENMESİ 
ÖZET 
Canlıların gözlerinde en ön kısımda yer alan kornea; saydam, esnek ve optik kırıcılık 
özelliği olan bir dokudur. Işığı kırma özelliğinin yanında, dış ortamdan gelen toz, 
mikrop ve benzeri zararlı maddelere karşı göz ve çevresini korumaya da yardımcı olur. 
Kornea bu koruma görevini sırasıyla kirpikler, kaşlar, göz kapakları ile birlikte 
gerçekleştirir. 
Koruyucu özelliği dışında korneanın bir diğer önemli görevi gözün toplam ışık 
kırıcılığının % 75 ini sağlamasıdır.   
İnsan gözünde genetik veya çevresel etkilerle meydana gelen Keratokonus hastalığı , 
kornea tabakasının esneklik özelliğini yitirmesi sonucu, incelerek, huni biçiminde öne 
doğru sivrileşmesidir. Bu şekil bozukluğu korneada ışığı kırma işlevini etkileyerek, 
ileri derecede astigmatizmle birlikte, gözlük kullanılarak düzeltilemeyecek görme 
kusurlarına yol açar. Daha ince bir çerçeveden bakıldığı zaman Keratokonus 
hastalığının altında yatan sebebin , korneada nano boyutlu kolajen fibrillerin 
arasındaki çapraz bağların zayıflaması sonucu ,esnekliğin yitirilmiş olduğu görülür. 
Bu çapraz bağları arttırabilme düşüncesinden yola çıkılarak Keratokonus hastalığı için 
günümüzde tüm dünyada etkin bir şekilde kullanılan “ Korneada Çapraz Bağlama “ 
kısaca CCL denilen tedavi önerilmiştir. Basitçe ışıkla etkileşebilen Riboflavin( B2 
vitamini) ve UV-A ışınının etkileşmesi olarak açıklanan CCL; Keratokonusun 
ilerlemesini tamamen durdurur ve gerilemesine yardımcı olur. CCL düşük maliyetlerle 
gerçekleşen, hızlı ve kolay bir tedavidir.  
Riboflavin maddesi UV-A ışınla etkileştiğinde meydana gelen kimyasal reaksiyon 
sonucu serbest oksijen radikalleri ortaya çıkar. Bu serbest oksijen radikalleride kolajen 
fiberler arasına tutunarak kovalent bağ yapımını sağlar. Meydana gelen kovalent 
bağlar aracılığıyla da, çapraz bağlanmadan ötürü daha önce esnekliğini yitirmiş olan 
kornea kolajen fiberleri gittikçe birbirlerine daha sıkı tutunarak, kornanın ilk 
elastikliğini kazanmasına yardımcı olur.  
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Rutin olarak kullanılan CCL de %0,1 Riboflavin, % 20 Dextranla birlikte tuzlu su 
içerisinde çözdürülerek korneaya damlatılır. 370 nm dalga boyunda 3mw/cm2 lik 
enerjiye sahip ışıkla kornea etkileştirilerek, korneada bir reaksiyon gerşekleşmesine 
sebep olur. Bu reaksiyon sonucu açığa çıkan serbest oksijen radikalleride korneada 
nano boyutlu kolajen fibriller arasında çapraz bağların oluşumuna sebep olur. Bu 
çapraz bağlar korneada biyomekaniksel işlevi arttırarak, daha önceki esnekliğini 
kazanmasına sebep olur. 
Yukarıda adı geçen Dextran maddesi; bir çeşit polisakkarit olup, tedavi süresince 
korneanın yeterince ıslanmasını ve şişmesini sağlamak için kullanılmıştır. 
Korneada çapraz bağlama tedavisi Keratokonus hastalığı için kullanılan ve başarılı 
sonuçlar alınan bir yöntem olmasına rağmen hala tüm hastalar için uygun değildir. İlk 
olarak kornea kalınlığı 400 µm den daha ince hastalara uygulanamamaktadır. İkinci 
olarakta tedavi sırasındaki sıcaklık artışı gözde kuruluğa, yanmalara sebep olabilir. Bu 
durumda göz yaşı damlası önerilir fakat bu damla da tedavide kullanılan solüsyonu 
seyrelttiği için tavsiye edilmez. Kornea protein yapılı olduğundan ve arkada bulunan 
mercekten dolayı yüksek sıcaklık bu yapıların bozulmasına dahası katarakta sebep 
olur. 
Sunulan bu tez çalışmasında öncelikle rutin tedavide kullanılan solüsyona alternatif 
solüsyonlar üretilmeye çalışılmıştır. Bunun için Dextran yerine maliyeti düşürebilmek 
adına daha ucuz bir diğer polisakkarit olan Dextrin ve tuz yerinede korneanın 
beslenmesinde görev alan glikoz kullanılmıştır. Riboflavinin %0,1 olan kritik 
konsantrasyon değerine ek olarak daha büyük (%0,2) ve daha düşük (%0,04) 
konsantrasyon değerleri seçilmiş, böylelikle Riboflavinin konsantrasyon değerinin 
tedavideki etkinliği araştırılmıştır. Alternatif solüsyonlardan hangisinin tedavide 
kullanılabileceğini saptayabilmek için bazı fiziksel parametreler belirlenmiştir. Bu 
parameterlerin ölçülmesiyle korneada çapraz bağlama tedavisinin geliştirilmesi 
hedeftir.  
Bu parametrelerden ilki sıcaklıktır. Sıcaklığın 1ºC bile artması korneanın protein 
yapısını bozabileceğinden ,sıcaklık değişiminin tedavi üzerideki etkisi önemle 
araştırılmıştır. Bu araştırma için de belirleyici olduğu düşünülen 3 sıcaklık değeri 
seçilmiştir. 24°C (oda sıcaklığı), 34°C (kornea sıcaklığı) ve 41°C (yüksek ateş 
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sıcaklığı) değerleri seçilerek tüm konsantrasyonlar için sıcaklığın zamanla değişimi 
incelenmiş ve sonuçlar değerlendirilerek solüsyonların davranışları gözlemlenmiştir.  
Solüsyonlar UV-A ışımasına tutularak time-drive grafikleri oluşturulmuş, bu 
grafiklerin eğimleri ile Fick’in İkinci Difüzyon Yasası kullanılarak tüm solüsyonların 
difüzyon katsayıları hesaplanmıştır. Difüzyon katsayısı büyük olan solüsyon, cornea 
tarafından daha iyi emileceğinden , alternatif olarak önerilmeye adaydır.  
Işımadan önce ve ışımadan sonra ki pH değerleri ölçülerek, korneanın pH toleransına 
en uygun solüsyona karar verilmiştir. Eğer pH değeri kornea tolerasının dışında bir 
değerse gözde geri dönüşü olamayacak türde kimyasal yanıklara sebep olabilir.  
Bu nedenle pH seviyesinin değişimi alternatif solüsyon önerilmesinde önemsenmiştir. 
Bir diğer paramatere olarak UV-A öncesinde ve sonradında viskozite değişimi olarak 
belirlenmiştir. Viskozite değerinin büyük olması solüsyonlar için tercih edilebilecek 
bir durumdur. Çünkü çapraz bağlama tedavisi sırasında göze damlatılan solüsyonun 
mümkünse gözden akmaması, olduğu yerde muhafaza edilmesi, solüsyonun kornea 
tarafından iyice emilmesi açısından önemli bir kriter olarak belirlenmiştir. 
Viskoziteleri ölçülerek, korneada çapraz bağ mekanizmasının işlerliği kontrol 
edilmiştir. Ayrıca viskozitenin , kayma gerilimi etkisi altında değişip değişmemesine 
bakılarak solüsyonların Newtonyen ya da Non-Newtonyen bir davranış sergilediği 
söylenebilmiştir. 
Yapılan bu tez çalışması sonucunda deney boyunca incelenen tüm fiziksel 
parametreler için elde edilmiş sonuçlar derlenerek tedavide kullanılabilecek alternatif 
bir solüsyon önerilerilebilmiştir. 
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1.INTRODUCTION 
Genetically or enviromentally occurance of Keratoconus illness in human eyes causes  
thinner cornea with lose of transparency. Thinner cornea tends to bulg outward like a 
cone shape. As a result of Keratoconus cornea can not refract the light correctly and 
some eye disorders are occured which can not be suppported by eye glasses. Collagen 
Cross Linking (CXL or CCL)  is suggested in this study to overcome these eye 
disorders. By the application of CXL with proper corneas , firstly cornea gain its 
primer elasticity, curvature of it becomes better and the illness of Keratoconus is 
stopped completely. In the CXL treatment, UV-A radiation and riboflavin (B2 
vitamine) in the solution are reacted. Free oxygen molecules came out from this 
reaction  cause links between nano dimensional fibrilles and collagen cross linking are 
observed. However, CXL can not be applied to the eye that has a thickness of cornea 
under 400 µm because of chemical burn of cornea bottom layers by UV-A radiation. 
Another risk of the treatment is occurance of edemas on the eye and degeneration of 
DNA structure. In this Master of Science thesis study, different riboflavin 
concentrations of routine  0,1 % riboflavin-dextran-saline solution will be used for 
CXL treatment. Beside this the solutions will be prepared with dextrin instead of the 
dextran which is another polysaccharids. For the solution instead of salt glucose will 
be used which has an effect on the nutrition of the cornea, alternatively. For all the 
potential solutions temperature, pH, diffusion coefficient and viscosity are selected as 
physical control parameters. Measurement of temperature differences at 24°C (room 
temperature), at 34°C (cornea temperature) and at 41°C (high fever temperature) will 
be realized, pH, viscosity values will be measured and diffusion coefficients will be 
determined by time-drive measurements, respectively. By using these measurement 
results proper solution ingredients will be tried to determine for the CXL treatment of 
all thickness type corneas. Another purpose of the study is analysing the causes of the 
CXL treatment side effects to give suggestions for the elimination of these side effects.    
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2.CORNEA 
 
2.1 Anatomy of the cornea  
The human eye is a complex optical structure which is sensitive to a light wavelength 
between 380 and 760 nm. The cornea that primary refractive element of the eye, 
spreads over 1/3 part of the eye (in the white part which is called sclera) and is a clear, 
transparent, elastic and relatively thick tissue that acts as a physical barrier between 
the external environment and the internal ocular elements.  It is as smooth and clear as 
glass, strong and durable. It does not contain blood vessels to nourish or protect it 
against infections and also because of containing no blood vessels; it stays transparent 
and can refract and focus light properly. The transparency of the human cornea 
depends on the regular lattice arrangement of the collagen fibrils and on the 
maintenance of an optimal hydration—the achievement of both depends on the 
presence of stromal proteoglycans (PGs) and their linear sidechains of negatively 
charged glycosaminoglycans (GAGs). The cornea consists of 78% water, 15% 
collagen, 5% mucopolysaccharidosis, proteins (albumin, globulin), lipids, vitamins 
and 1% GAGs.  
In humans, has a thickness of  0.5-0.6 mm in the center and 0,67 mm in the peripheral 
together with  a horizontal radius as 12,6 mm and a vertical radius as 1,2 mm. The 
radius of curvature is 7.8 mm anterior and 6.5 mm posterior. The surface area of cornea 
is 1.3 cm2. The refractive power is 45 D (diopters) and this provides to contribute 75 
percent of the eye’s total focusing power of 60 D. The refractive index is 1,378. The 
biological development of the cornea lasts until age 6. [1]Unlike humans, cornea exists 
only which have iris/lens in animals. [2][3][4] 
Corneal temperature is about 10 ° C below body temperature, which is caused by direct 
contact with moist surface of the cornea and external environment, as well as the lack 
of blood vessels. When the eyelids are closed, corneal temperature nearby the limbus 
is about 35,4ºC and 35,1 ºC in the center (with eyelids open~30 ºC)[5]. 
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Figure 2.1: The view of the cornea from front[6]. 
Cornea mainly has two important role in the eye. Firstly; it helps to shield the rest of 
the eye from germs, dust, and other harmful matter. The cornea shares this protective 
task with the eyelids, the eye socket, tears, and the sclera, or white part of the 
eye.  Secondly acts as the eye's outermost lens. It functions like a window that controls 
and focuses the entry of light into the eye. The cornea contributes between 65-75 
percent of the eye's total focusing power. Having many nerve cells makes cornea very 
sensitive against to the external environment. Nerve fibrils save cornea’s health and 
provide continuation by the help of blinking reflex and supportive properties. The 
avascular structure of the cornea let the most successful operations exist from human 
to human for the first time[1]. In Figure 2.2 the structure of the eye can be seen from 
interiour. 
 
Figure 2.2: The structure of the eye from interior[7]. 
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2.1.1 Layers of the cornea 
Cornea has five different layers;    Anterior epithelium 
                                                        Bowman’s layer 
                                                        Central stroma 
                                                        Descement membrane 
                                                        Endothelium 
 
 
Figure 2.3: Layers of cornea[8]. 
 
Anterior epithelium is almost 50 microns thick. It has the ability of regeneration and 
provides smooth surface for cornea. It is formed of three types of cells. On top there 
are surface cells which are thin, squamous and overlapping polygonal ones covering 
two layers. Secondly Wings cells overlay basal layer covering two layers. Wings 
protrude into space between domes of basal cells. Lastly the inner basal cells have one 
layer of columnar cells. In anteriour epithelium the time required for basal cells to 
migrate anteriorly to become surface cells is approximately seven days. The glucose 
and oxygen are needed most by epithelium within all layers of cornea and it can 
provide this necessity from atmosphere by tear films, from the capillary nearby limbus 
or from aqueous humor by diffusion. 
Bowman’s layer is cellular mass of condensed collagen fibrils. The thickness of it 
between 8 to 14 microns. It is a thin and elastic membrane. Although Bowman’s layer 
shows considerable resistance to infections and injuries, once it is destroyed, can’t be 
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regenerated. After it is destroyed, is replaced by opaque scar tissues. Stroma is about 
500 microns thick and that means 90 percent of total thickness of cornea. It is consist 
of collagen fibrils (lamellae) and the cells are embedded in hydrated matrix of 
proteoglycans. The corneal stroma is hard to be punctured or cut including 2-3% 
hepatocytes and 1% GAGs. It is composed of about 200-250 flattened lamellae, 
superimposed one on another. 
 
Figure 2.4: Layers of cornea-2[9]. 
Descement’s membrane represents the basement membrane of the endothelium. It is 
highly elastic and cellular structure that made up of collagen and glycoprotein. It has 
a thickness of 10 to 12 microns. It shows very resistant to chemical agents, trauma, 
infections and pathological processes. Descement’s membrane maintains integrity of 
the eyeball. If it is destroyed somehow, it can regenerate. 
Endothelium is single layer of flat hexagonal cells. It has a mosaic pattern.  The cell 
density is between 2400 and 3000 cells/mm2 and contains an active pump mechanism. 
This layer pumps water from the cornea, keeping it clear. In a healthy eye, a perfect 
balance is maintained between the fluid moving into the cornea and fluid being 
pumped out of the cornea. The endothelium cells do not have the ability of 
regeneration. If there exists too much damage to the endothelium cells, it can lead to 
corneal edema (swelling caused by excess fluid)[9]. In Figure 2.3 and 2.4 the layers of 
the cornea are seen. 
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 2.1.2 Collagen structure of the cornea 
The collagen is a major protein which provides the tensile strength, facilitate 
transparency, provide form during embryonic and fetal development , interact with the 
other proteins to build tissues and organs, separate cell layers during /after 
development and provide filtration barrier between spaces. 
 
Figure 2.5: The structure of a typical collagen molecule[10]. 
 
Above in the Figure 2.5 the top panel represents a single collagen molecule, which 
always consists of three protein chains. Each chain is an alpha helix, and in type I 
collagen molecules there are two alpha 1 chains and one alpha 2 chain, which is 
abbreviated as [α1(I)]2 [α2(I)]. The three protein chains (wound into a triple helix) 
make up one collagen molecule. The red line shown in one of the strands of the triple 
helix represents the alpha helical winding of the peptide backbone of that peptide 
chain. As shown in the bottom panel, each triple-helical collagen molecule is 300nm 
long and forms a rod. Collagen molecules spontaneously assemble in a head-to-tail 
alignment with a small gap that separates the 'head' of one molecule with the 'tail' of 
the next molecule, and in a staggered side-by-side arrangement. Adjacent collagen 
molecules are displaced about 67nm, or slightly less than one-fourth of the length of a 
single molecule. The side-by-side interactions are stabilised by covalent bonds (red 
bars) between the N-terminus of one molecule and the C-terminus of an adjacent 
molecule [10][11][12]. 
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Figure 2.6: Collagen dimensions[12]. 
The C-terminus (also known as thecarboxyl-terminus, carboxy-terminus, C-terminal 
tail, C-terminal end, or COOH-terminus) is the end of an amino acid chain 
(protein orpolypeptide), terminated by a freecarboxyl group (-COOH). 
The N-terminus (also known as the amino-terminus, NH2-terminus, N-terminal 
end or amine-terminus) refers to the start of a protein or polypeptide terminated by 
an amino acidwith a free amine group (-NH2)[13]. In Figure 2.6 the different collagen 
dimensions are shown. 
There are different types of collagens distributed in the cornea. These are respectively 
type I, III, IV, V, VI, VII and VIII scattered throughout the  different layers of 
cornea[14]. The Figure below show the collagen distibution of all cornea’s layer. 
 
 
Figure 2.7: Collagen distribution in the cornea[15]. 
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2.1.3 Disorders of the cornea 
The term "corneal disease" refers to a variety of conditions that affect mainly the 
cornea. These include infections, degenerations, and many other disorders that may 
arise mostly as a result of heredity. With its ability for quick repair, the cornea usually 
heals after most injury or disease.  However, when there is deep injury to the cornea, 
the healing process may be prolonged, possibly resulting in a variety of symptoms, 
including: 
 Pain 
 Blurred vision 
 Tearing 
 Redness 
 Extreme sensitivity to light 
 Corneal scarring 
There are several conditions that can affect the cornea, including infections (such as 
bacterial or viral keratitis), trauma, genetic disorders, degenerative disorders, 
autoimmune disorders, nutrition deficiencies, allergies, dystrophies and ecstatic 
disorders (such as keratoconus), inflammatory diseases,  and growths. The cornea 
can also be damaged secondarily by other eye conditions such as tear film 
abnormalities and dry eye, eyelid disorders, and glaucoma[16][17]. In Figures 8 and 
9 one of the abnormalities of the cornea called blurring is seen. 
 
 
 Figure 2.8-9: Blurring of the vision as a symptom of cornal illnesses[18].  
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3.KERATOCONUS AND CROSS-LINKING 
3.1 Keratoconus Illness 
Keratoconus is a corneal disorder that letting cornea to become thinner and to be 
conical rather than its normal shape because of the structural degenerations. 
The name of Keratoconus is a combination of  ‘Kerato’ comes from Greek language 
and means cornea and ‘conus’ is again from Greek language and means conic or like 
a cone shape. Though there is not an exact reason but some researches indicate that 
Keratoconus can occur genetically, environmentally or the endocrine system may be 
playing a role about[19]. 
The genetical reason for Keratoconus that there is less than a one in ten chance that a 
blood relative of a keratoconic patient will have keratoconus. The majority of patients 
with keratoconus do not have other family members with the disease. Some research 
suggests the weakening of the corneal tissue that leads to keratoconus may be due to 
an imbalance of enzymes within the cornea. This imbalance let the cornea to be 
threatened easily against oxidative damages from free radicals and this causes to being 
weak and bulge forward. According to the other thoughts, the lack of important 
anchoring fibrils that structurally stabilize the anterior cornea. This causes an 
increasing flexibility and allows cornea to bulge forward into a cone-shaped 
apperance. Moreover Keratoconus is likely to happen by overexposure to ultraviolet 
rays from the sun, excessive eye rubbing, a history of poorly fitted contact lenses and 
chronic eye irritation.  Another hypothesis is that the endocrine system may be 
involved because keratoconus is generally first detected at puberty and progresses 
during pregnancy.  This theory is still controversial and has not been proven.  
  In a Keratoconic eye, when the light enter from cornea, it can not focus on retina 
correctly because of the formless cornea shape and so Keratoconus causes a number 
of changes to eyesight, including astigmatism as the cornea changes from a ball shape 
to a cone shape, the smooth surface becomes slightly wavy, nearsighted as the front of 
the cornea expands, only nearby objects can be seen clearly and anything too far away 
will look like a blur, blurring of vision, bright lights appearing to be streaked, glare 
and halos appear at night [20][21][22][23]. 
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Figure 3.1: A Keratoconic eye[24]. 
 
                    Figure 3.2: The difference of light rays focusing between normal 
                                              and Keratoconic eye[25].  
 
Keratoconus is a progressive condition that affects approximately 1 in 500 people. It 
is an inherited and degenerative disorder, and is usually first diagnosed in the teenage 
or early adult years. Both eyes may not be affected same in this illness and it occurs in 
all ethnic groups with no male or female preponderance. The progression of 
Keratoconus usually lasts 10 to 20 years and then it  slows down. Rigid contact lenses 
and intracorneal ring segments have helped correct prescriptive error, but they don’t 
prevent further progression of Keratoconus. In Figure 3.1 Keratoconic eye is shown 
and in Figure 3.2 comparing both normal and the keratoconic eye are given. 
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3.2 Cross-Linking (CXL) Treatment 
CXL is a new and a minimally invasive technique that increases the collagen crosslinks 
which are the natural “anchors” within the cornea.  These anchors prevent the cornea 
from bulging out and becoming irregular.  
  Basicly the aim of the CXL treatment is to create additional chemical bonds between 
the collagen fibers of corneal stroma by photopolymerization. By the increasing 
chemical bonds, it provides mechanical stability of corneal tissue and the treatment 
focuses on halting the progression of the diseases such as ectasias which are 
characterized by irregular curvature and diminished thickness of the cornea. 
Keratoconus is the most common indication for corneal collagen cross-linking.  In this 
treatment a combination of Riboflavin drops (B2 vitamine) and ultra violet light are 
used which react with the tissues in the cornea and cause strengthening them by 
creating more ‘cross-linking’ among in the cornea. This reaction causes an increased 
stiffness and rigidity of the cornea stabilises ectasia and prevents further deterioration 
in vision and the need for corneal transplantation. In Figure 3.3 the crosslinks between 
the collagen fibers are seen[25][26]. 
 
 
 
 
 
 
Figure 3.3: Increased crosslinks between the collagen fibers[27]. 
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  In Figure 3.4  the collagen crosslinking mechanism is given. 
 
 
 
      
 
 
Singled form of the riboflavin is excited by UV light and then 
 while transferring to triplet form it emits green lights. 
--CH2--CH2--CH2--CH2 = NH--CH2--CH2--CH2--CH2--   
                                                                                                          
                                       
 
  
 
Figure 3.4: Process of the crosslinking mechanism[28]. 
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The  CXL of the nanofibrilles enhances 
the resistant and the rigidity of the 
cornea 
Collagen fibril 
As a result of this reaction singlet oxygen is formed to 
tide amino groups of the collagen nano fibrilles by 
covalent bond. 
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3.2.1 Procedure of the current treatment 
 
 Corneal cross-linking was discovered at the Dresden Technical University in 
1998 and its first use for Keratoconus treatment was explained by Gregor 
Wollensak and colleagues in 2003[29]. 
 At the begining of the treatment,  the central 7 mm diameter area of the corneal 
epithelium is removed with a mechanical spatula to let the solution enter the 
cornea easily. 
 Next, a solution of riboflavin (vitamin B2 in the solution of dextrane T500 and 
saline) is dropped on the cornea every 5-10 minutes within a 30- minute period 
before UVA irradiation.  
 UVA radiation of 370± 𝟓 nm wavelength and an irradiance of 3 mW/cm2 at a 
distance of 5.4 mm from the cornea is applied for a period of 30 minutes, 
delivering a dose of 5.4 J/cm2 . 
 Antibiotic eye drops are instilled as prophylaxis and a bandage contact lens is 
inserted, which is then removed at the followup visit once epithelial healing is 
complete[30][31][32]. 
The Figure 3.5 is explaning the formation of crosslinking. 
 
 
 
Figure 3.5: The unique procedure of the CXL[33]. 
Drops of  
a 0.1% riboflavin solution  
in 20% dextran 
are instilled onto the 
cornea  
every 3 min for 30 min. 
Formation of 
Cross-linking 
The cornea is exposed 
to UV light with  
a wavelength of  
370  5 nm 
 and 
an irradiance of  
3 mW/cm
2 
 
for a total time of  
30 min 
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3.2.2 Insufficiencies and possible side effects of the CXL 
There were some studies done about the safety procedure of the cornal cross-linking. 
These studies determined the important points which have to be taken under 
consideration and  safety cryterias of the treatment. 
 The duration of the treatment should not be too long. 
 The transparency of the cornea should not be changed. 
 The cross-linking effect should only include the cornea[34]. 
The CXL is a quite safe procedure. Only one thing is reported as a threat for the corneal 
healt. This is the corneal edema as a result of the UV-A damage to the corneal 
endothelium  in the corneas which has a thickness of less than 400µm[35]. 
 There are another studies done about the removal of corneal epithelium. In the first 
application of  the treatment procedure, the corneal epithelium is removed from the 
eye with a mechanical spatula in order to let the solution penetrate throughout the 
cornea well. Then it is thought to be left in the cornea because it is understood that, in 
the presence of the epithelium, less crosslinking is occured and it causes a barrier 
against to the crosslinking of the collagen fibrilles[35]. The safety requirements of 
CXL are mentioned in Figure 3.6. 
 
Figure 3.6: Safety requirements of the CXL with UV-A& Riboflavin[34]. 
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4.CHEMICALS AND SOLUTIONS 
4.1 Riboflavine 
Riboflavine, or Vitamin B2 is a redox-active substance that has an essential job in all  
living cells[36]. It is a yellow, water-soluble organic compound important for our 
health[37]. Rather than in the free form, Riboflavine is active more complex 
compounds known as coenzymes, such as flavin mononucleotide (FMN) and flavin 
adenine dinucleotide (FAD), or flavoprotein, all necessary for the processes that make 
energy available in human body. 
Riboflavin was isolated in pure form in 1933 and was first synthesized in 1935. It 
functions as part of metabolic systems concerned with the oxidation of carbohydrates 
and amino acids, the constituents of proteins[38]. In Figure 4.1 moleculer structure of 
Riboflavin is shown. 
 
Figure 4.1: Riboflavine structure[39]. 
Some important properties could be listed in the below: 
 
 Moleculer weight      : 376.3639 g/mol [39] 
 Moleculer formula    : C17H20N4O6 [39] 
 Exact Mass                : 376.138284 g/mol [39] 
 Physical Description : Orange-Yellow Crystals[40] 
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 Color                         : Fine orange-yellow needles from 2N acetic 
acid, alcohol, water, or pyridine ... three different crystal forms[41] 
 Taste                          :Bitter[42] 
 Melting Point             :280 °C[43] 
 Solubility                    :g/100ml at 25°C ; 0,01 in water [40] , slighlty 
soluble in alcohols,ethanol, insoluble in lipid solvents ,ethyl ether, 
acetone, chloroform[42][43], very soluble in dilute alkalies[44] 
 pH                                : pH of saturated aqueous solution: about 6[44] 
 
                 Figure 4.2: Riboflavine powder[45]. 
Some experimental properties also could be explained like; 
 Crystalline riboflavin shows no evidence of decomposition under ordinary 
conditions, but protection from light is advisable[46]. 
 Solutions prepared with Riboflavine undergo decomposition under the 
influence of visible or ultraviolet light[46]. 
 In neutral solution it is relatively heat stable if protected from light[47]. 
 Stable in acid solution and in the presence of oxidizing agents, but very 
sensitive to alkali and light[47]. 
 Visible or UV irradiation of alkaline solutions causes formation of lumiflavine. 
 Stable in most food applications[48]. 
 UV max absorption: 220-225 nm, 266 nm, 371 nm, 444 nm, 475 nm [44]. 
  Aqueous solutions are yellow showing a green fluorescence with max at 565 
nm[44]. 
Physically,dust explosion could be  possible if in powder or granular form of 
Riboflavine, mixed with air. Physical appearace of Riboflavin is shown in Figure 
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4.2. Moreover, chemically, it decomposes on heating and this produces toxic 
fumes[40].  Riboflavin may cause urine to have a more yellow color than normal, 
especially if large doses are taken. This is to be expected and is no cause for alarm. 
Usually, however, riboflavin does not cause any side effects[49]. 
4.2 Dextran 
Dextran is a group of glucose polymers ,first discovered by Louis Pasteur as a 
microbial product in wine. It is made by a certain bacteria. It is a complex, branched 
polysaccharide made of many glucose molecules joined into chains of varying lengths, 
used as an antithrombotic (anti-platelet), and to reduce blood viscosity[50][53]. 
Dextrans are also used therapeutically as plasma volume expanders and 
anticoagulants. Moreover they are commonly used in biological experimentation and 
in industry for a wide variety of purposes like pharmaceutical, photographic, and 
agricultural industries. Moleculer structure of Dextran is shown in Figure 4.3. 
 
Figure 4.3: Dextran structure[51]. 
Some important properties could be listed in the below: 
 Moleculer weight      : 504.43708 g/mol[51] 
 Moleculer formula    : H(C6H10O5)xOH [51] 
 Exact Mass                : 504.169035 g/mol [51] 
 Dextran is neutral and water soluble[52] 
 Dextran is easily filtered[52] 
 Dextran is biocompatible[52] 
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 Dextran is biodegradable[52] 
 Dextran is stable for more than 5 years[52] 
 Dextran is used in the osmotic stress technique for applying osmotic 
pressure to biological molecules[53] 
Dextran fractions are characterized by their average molecular weights and 
molecular weight distributions. Dextran fractions are supplied in molecular 
weights from 1,000 Daltons to 2,000,000 Daltons (1). The molecular weight of the 
fraction is in most cases a key property and is defined in terms of the average 
molecular weight Mw (2) and the number average molecular weight Mn (3). 
The molecular weight distribution curve for each fraction obtained by gel 
chromatography offers a unique method for characterizing the Dextran fraction.  
Dextran fractions behave as very flexible and extended polymers and in solution 
exist as an expandable coil[52]. 
 
Table 4.1: Moleculer Dimension(Stoke’s Radius) of Dextran[52] 
MW*10-3 Stoke’s Radius(nm) 
2000 
 
27 
1000 
 
19.9 
500 
 
14.7 
200 9.5 
 
100 
 
6.9 
70 
 
5.8 
50 
 
4.95 
40 
 
4.45 
10 2.36 
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Figure 4.4: Dextran powder[53] 
Dextran fractions are readily soluble in water and electrolyte solutions to form clear, 
stable solutions. The pH does not affect solubility significantly. Concentrated solutions 
(> 50% w/v) may be prepared. 
Dextran fractions are also soluble in some other solvents, notably, methyl sulfide, 
formamide, ethylene glycol, and glycerol. Dextran fractions are insoluble in 
monohydric alcohols, for example methanol, ethanol and isopropanol, and also 
most ketones, such as acetone and 2-propanone. Although Dextran fractions will 
form clear solutions, it should be noted that the lowest molecular weight fractions 5 
and 10 may, on standing, form turbid solutions, particularly when concentrated 
solutions are used. 
The effect which told in the above may be delayed by boiling the solutions 
immediately after preparation. Dextran fraction solutions can be filtered without 
difficulty. More concentrated solutions will require larger filters or filter series and 
higher pressures in order to increase the rate of filtration. Further increases in filtration 
rates may be achieved by raising the temperature. The dimensions of the filter system 
must be related to the volume and concentration of the Dextran solution used. Dextran 
fraction solutions exhibit Newtonian flow characteristics, that is, the flow rate is 
independent of shear stress[51] 
(1)Da : When nothing is indicated molecular weight units are assumed to be Daltons. 
(2)Mw : Weight average molecular weight of Dextran fractions. 
(3)Mn : Number average molecular weight of Dextran fractions. 
 20 
Upon light exposure a higher, degree of substition results in higher crosslinking 
density which in turn decreases the degree of swelling and the water content[53] 
There are a few side effects associated with the use of Dextran. These effects could be 
quite serious. Anaphylaxis, volume overload, pulmonary edema, cerebral edema or 
platelet dysfunction. Moreover acute renal failure could be seen not uncommon but 
significantly as a dextran osmotic effect. The pathogenesis of this renal failure is the 
subject of many debates with direct toxic effect on tubules and glomerulus versus 
intraluminal hyperviscosity being some of the proposed mechanisms. People who have 
a past with diabetes mellitus, renal insufficiency or vascular disorders are in danger 
most. Also patients with chronic renal insufficiency are recommended to avoid the 
dextran therapy[52] 
4.3 Dextrin 
Dextrins are a group of low-molecular-weight carbohydrates produced by 
the hydrolysis of starch. Dextrins are mixtures of polymers of D-glucose units linked 
by α-(1,4) or α-(1,6) glycosidic bonds. 
Dextrins can be produced from starch using enzymes like amylases, as during 
digestion in the human body and during malting and mashing, or by applying dry heat 
under acidic conditions (pyrolysis or roasting). The latter process is used industrially, 
and also occurs on the surface of bread during the baking process, contributing to 
flavour, colour and crispness. Dextrins produced by heat are also known 
as pyrodextrins. During roasting under acid condition the starch hydrolyses and short 
chained starch parts partially rebranches with α-(1,6) bonds to the degraded starch 
molecule[54] In Figure 4.5 the moleculer structure of Dextrin is seen. 
 
Figure 4.5: Dextrin Structure[55] 
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Some important properties are listed as in the below: 
 Moleculer formula    : (C6H10O5)n [56] 
 Moleculer weight      : variable[56] 
 Physical Description : DryPowder [56] 
 Color                         : Colors range from white to tan, the lightest being the 
best grades.[57] 
 pH                               : 4.5-4.7(%1 Solution) [57] 
 Viscosity                     :a 1% solution may reach a viscosity of 3,300 cP; 
viscosity decreases with temperature[57] 
 Solubility                  :one of the least soluble of the gums,  absorbs water to 
form viscous solutions at low concentration[58] 
 
 
Figure 4.6:Dextrin powder[53]. 
 
Some other experimental properties could be explained as below: 
 Carbohydrate polymer of varying chemical composition, properties depend on 
freshness and time of storage[59] 
 Electrolytes & excess acid can also cause drop in viscosity[57] 
 Color of solutions lighten in acidic media, darken in alkaline media due to 
presence of tannins[60] 
 Absorbs water rapidly to form viscous mucilages at low concentrations; 
viscosity decreases on additionn of acid or alkali; loses viscosity forming 
ability when stored in the dry state, the loss being greater for a powdered 
material than for the crude gum; cold storage inhibits this degradation[60] 
 Above ph 7 solution become irreversibly transformed into a ropy, stringy 
mucilage[57] 
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Dextrins are partially or fully water-soluble, yielding optically active solutions of low 
viscosity. Most can be detected with iodine solution, giving a red coloration; one 
distinguishes erythrodextrin (dextrin that colours red) and achrodextrin (giving no 
colour). White and yellow dextrins from starch roasted with little or no acid is called 
British gum[54] 
There are observed some allergic reactions, characterized by urticaria, rhinitis, 
dermatitis, & asthma. They have been attributed to powdered karaya (sterculia) 
gum[61] Figure 4.6 show the physical appearance of Dextrin. 
4.4 Salt 
Salt is the common name of the chemical compound named as sodium chloride. It is 
one of the most important chemical compound for the human body. Salt makes 
our food safe and pat able. We get salt form the sea. In our body, blood has the similar 
chemical balance of sodium, potassium, calcium. The chemical formula of the salt is 
NaCl. The physical properties of the salt determine how the salt is produced and used. 
Salt is a crystalline solid and found in the cubic form along with the seawater as the 
salty lake water evaporates due to heat energy of sun. It is isomeric in nature[62] The 
Figure 4.7 there can be seen the moleculer structure of sat crystal. 
 
Figure 4.7: Structure of salt crystal[62]. 
Some important properties about Glucose are listed in the below: 
 Moleculer weight      : 58.44 g/mol 
 Moleculer formula    : NaCl 
 Synonyms                 : Salt; Rock Salt; Saline; Table Salt 
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 Physical Description : White crystals 
 Color                         : White 
 Density                      : 2.2 ×103 kg/m3 
 Solubility                  : 36g/100ml water (@ 20°C) (68°F) 
 pH                              : 6.7 - 7.3 (aqueous solution) 
 Boiling Point             : 1413°C (2575°F) 
 Melting Point            : 801°C (1474°F) 
 Vapor Pressure          : 1.0 mmHg (@ 865°C) (1589°F) 
Usage of salt has some potential health effects. It may cause mild irritation to the 
respiratory tract. Also to use very large doses of salt can cause vomiting, diarrhea and 
prostration. Deydration and congestion ocur in most internal organs. Hypertonic salt 
solutions can produce violent inflammatory reactions in the gastrointestinal tract. 
Moreover it may irritate damaged skin; absorption can ocur with effects similar to 
those via ingestion. If it contacts with eye; may cause irritation, redness and pain. This 
occurs for salt concentrations greater than the normal saline present[62][63]. 
 
4.5  Glucose 
Glucose is the primary source of energy for living organisms. It is naturally occurring 
and is found in fruits and other parts of plants in its free state. It is used therapeutically 
in fluid and nutrient replacement. 
Glucose is a monosaccharide which is absorbed directly into the blood stream during 
digestion. It is an important carbohydrate in biology, which is indicated by the fact 
that cells use it as a secondary source of energy and a metabolic intermediate. Glucose 
is one of the fundamental products of photosynthesis and fuels for cellular 
respiration[64]. The moleculer structure of Glucose is seen in Figure 4.5. 
 
Figure 4.8: Glucose structure[65]. 
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Some important properties about Glucose are listed in the below: 
 Moleculer weight       : 180.15588 g/mol  
 Moleculer formula     : C6H12O6  
 Exact Mass                 : 180.063388 g/mol  
 Physical Description  : Liquid; DryPowder; WetSolid 
  Color                         : White 
 Taste                          :Sweat 
 Melting Point             : 146 °C 
 Solubility                    : water soluble 
 Density                       : 1,56 (relative to water=1g/cm3) 
In some cases dust explosions could be seen associated with the use of Glucose  if in 
powder or granular form, mixed with air  and  also Glucose  reacts violently with strong 
oxidants[66]. 
 
4.6  Tears 
Tear film is an important element of the ocular environment. In addition to its main 
task that to provide a smooth optical surface ,also it protects and lubricates the surface 
exposed to the ocular environment[67]. 
Tear film is the combination of the three layers. On the uppermost there is the lipid or 
fatty layer. It prevents rapid evaporation of the aqueous layer. In the middle there is 
aqueous layer. It consists of 98% water and the other 2% are dissolved salts and 
proteins. The aqueous layer is the thickest layer of the tear film and it supplies oxygen 
to cornea, moisturaises and nourishes the cornea and saves cornea againts to foreign 
bodies like dust,germs.. 
The lower part layer of the tear film is the mucin layer. It is athin layer of mucus. The 
mucin layer provides that the tear film can adhere to the ocular surface[68]. 
Layer of the tear fim is shown in Figure 4.9. 
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                               Figure 4.9: Tear film and it’s layers. 
Functions of the tear film can be listed in the below: 
 Protection of the eye against the foreign bodies dusts pollens,viruses..etc 
 Nutrition and oxygen supply to the cornea 
 Protection against drying of the cornea 
 Gliding layer for the eyelids 
 Smoothing of the optical surface of the eye for clear vision[68] 
Some important properties of the tear film can be listed in the below: 
 pH                    : 7.30 to 7.70 
 Osmolality        : 244 to 344 mOsm/kg 
 Viscosity           : 1 to 10 cP 
 Surface tension : 42 to 46 mN/m14[67] 
4.7 Solutions Used In This Study 
In the current  C.X.L procedure a solution that the combination of 0,2 ml 0,5% RF-5 
phospate and 20% Dextran T-500 (0,2g) dissolved in 0,8 ml 0f 0,9 % physiologic 
saline solution is used.  Here Riboflavine is the photosensitizer which reacts with UV-
A radiation, Dextran and saline is used to reduce overswelling against the corneal 
edema. 
In this study in addition to the treatment solution, another 8 different solutions are 
prepared by the different combination of Riboflavine, Dextran, Dextrin, Salt, Glucose 
and distilled water with three different Riboflavin concentrations. These 
concentrations are 0,1%, 0,2% and 0,04%.  
These all 9 solutions are mentioned in the table 4.2 below. 
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Solute(g) 
Table 4.2: Solutions used in this study. 
Solution Content 
1 
 
RF+ dH2O 
2 
 
RF+ Saline 
3 
 
RF+Glucose+ dH2O 
4 RF+Dextran+ dH2O 
 
5 
 
RF+ Dextran+ Saline* 
6 
 
RF+ Dextran+Glucose+dH2O 
7 
 
RF+ Dextrin+dH2O 
8 
 
RF+Dextrin+Saline 
9 RF+ Dextrin+Glucose+dH2O 
 
*employed solution in CXL treatment 
 
4.7.1 Preparations of the solutions 
The combination of 0,2 ml 0,5% RF-5 phospate and 20% Dextran T-500 (0,2g) 
dissolved in 0,8 ml of 0,9 % physiologic saline solution is the treatment solution. 
First of all to create any desired concentration it is better to start from 1%. 
To prepare 1% c  the steps are followed in the below.  
0,2 ml 0,5% RF-5 phospate means               0,5 %(
𝑤
𝑣
)                              
 
In 100 ml dH2O , 0,5 g RF exists so in 0,2 ml  there 
0,2.0,5
100
=0,001 g RF is dissolved and 
that value corresponds to 0,1% c RF. 
That means in 0,2 ml or 200µl dH2O  0,001 g RF has to be dissolved. 
Thus to create  1% c  RF, 
From the equation           c1.v1=c2.v2                                                                                                         (4.2) 
1. v1=0,1.0,2 ml 
v1=0,02 ml   or 20 µl. 
if in 20 µl dH2O, 0,001 g RF is dissolved, it is converted to in 200µl dH2O  0,01 g RF 
and this value corresponds to 1% c RF. 
Solvent(l) 
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To create the other concentrations we dilute 1% c RF solution. 
For 0,1% c 
10% part of the 200µl dH2O  with 0,01 g RF of 1% c solution is taken by the help of a 
pipette. 
200. 10%=20 µl. 
To complete 200 µl again , 180 µl dH2O is added  over to 20 µl solution with RF. 
For 0,2% c  
20% part of the 200µl dH2O  with 0,01 g RF of 1% c solution is taken by the help of a 
pipette. 
200. 20%=40 µl. 
To complete 200 µl again , 160 µl dH2O is added  over to 40 µl solution with RF. 
For 0,04% c 
Similor steps are followed to create 0,04% c RF mentioned in the above. 
4% part of the 200µl dH2O  with 0,01 g RF of 1% c solution is taken by the help of a 
pipette. 
200. 4%=8 µl. 
To complete 200 µl again , 192 µl dH2O is added  over to 8 µl solution with RF. 
The rest of the 800 µl of total solution, 
In 100 ml solvent  0,9 NaCl is dissolved and in 0,8 ml of that solution, 0,2 g X is 
dissolved. So; the amount of the NaCl in the solution calculated as ; 
     100 ml              0,9 g NaCl 
                                                  0,8 ml         ?    g NaCl                                              (4.3)  
0,0072 g NaCl is calculated. 
Moreover ;     
                                                 100 ml                20 g X 
                                                  0,8 ml                       ?  g X                                                       (4.4) 
So it is understood that in 800µl dH2O , there are 0,0072 g NaCl and 0,16 g X is 
dissolved.   
Finally it is understood that to create the treatment solution; 0,001 g RF dissolved in 
200 µl dH2O with 0,0072 g NaCl and 0,16 g X dissolved in  800µl dH2O are combined 
in the same quartz cuvette. 
If it is needed to create alternavtive solutions same amount of Dextrin (Y) is used in 
stead of X and same amount of Glucose is used in stead of Salt. 
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One of the important point about preparations in some cases at the beginning of the 
experiment it is needed to prevent the reaction between Riboflavine and the light so 
the quarts cuvette is preferred to cover with an aluminium foil. 
During the process to use a magnetic little mixer is preferable to provide a better and 
a quick solution that  includes all the substances are dissolved clearly. In Figure 4.10 
a solution which is prepared with Riboflavin is shown.  
 
Figure 4.10: Any solution with riboflavin in the quartz cuvette. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 29 
 
 
5. DETERMINATION OF THE PHYSICAL PARAMETERS  
 
  In order to overcome the insufficiencies of the crosslinking treatment in Keratoconus 
illness, there some physical parameters are determined to control the mecanism of the 
treatment. Respectively these parameters are temperature exchange, pH level, 
diffusion coefficients of the solutions and the viscosity values of the solutions. 
5.1 Temperature 
Temperature exchange is the first key parameter of the corneal crosslinking effect in 
Keratoconus illness because as told in the third chapter section 2.2, uncontrolled 
increase of the temperature let the CXL process to cause dryness or burns in the cornea. 
The protein structure of the cornea could be effected by the high temperature increase. 
This temperature increase may effect the transparency of the cornea and so the lens 
behind it, and this effect occurs as cataract. 
Temperature is the average kinetic energy of the molecules and it describes the 
thermometric state of the system. So the thermal exchange of the solutions in the 
treatment mean the average kinetic energy of the molecules which are exposed to a 
specific beam of light. Although the temperature exchange is related to the molecules’ 
mean free path. If any molecules of a system  have a large mean free path, it means 
the temperature exchange of the system is low. That makes us to focus on the relation 
between the temperature exchange and the various solutions. 
 
5.1.1 Mechanism Of Thermal Effect Experiment 
In order to avoid environment effects such as undesirable light and heat transmission 
from medium, closed systems are preferred in experiments. It is required to perform 
the experiment at constant temperature and to use a short wavelength light to prevent 
heat transfere and light leakaage respectively. 
In Figure 5.1 and 5.2 the closed system are seen. In that closed system, a UVA source, 
a slit that let UVA  light pass through, a barrier that blocks the light to pass through 
the slit, a cover and a space (generally rectangular shape) are included. The sample is 
placed in the cuvette holder and one side of the space is blanked for the incident light. 
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Figure 5.1: A handmade UV-absorbance spectrometer. 
 
All temperature changes are recorded with a multimeter. Multimeter is connected to 
the computer with a usb cable. So each data for every one second is measured and sent 
to the computer. By using UNI-T program, all data are saved in excel format. 
 
Figure 5.2: The open-view of the UV-absorbance spectrometer. 
 
To perform the experiment, the quartz cuvette that includes solution is placed in the 
rectangular space in the closed system. All samples are prepared with Riboflavin that 
have the ability of reacting with light so in order to avoid any reaction between the 
solution and light, quartz cuvette should be covered with an opaque film. Respectively 
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thermocouple is put in the solution then the cover of the system is closed. To let the 
light pass through cuvette, the barrier must be removed from front part of the slit. 
Before radiation UNI-T program is started and during 30 minutes, UV-A light is sent 
through the sample. After cleaning the quartz cuvette and themocouple with distilled 
water, a new sample can be replaced in the rectangular space in the closed system if 
required. In Figure 5.3 the diagram of the experimental setup is shown. 
 
 
Figure 5.3: Diagram of the experimental setup. 
5.1.2 Measurements for Temperature exchanges of the solutions 
Related to the three different concentrations 0,1% (the critical), 0,2% (greater than the 
critical), 0,04% (less than the critical) with nine different solutions, thermal exchange 
experiment is done with three different temperature degrees. These temperatures are 
24°C (the room temperature), 34°C (the cornea temperature) and 41°C ( high fever 
temperature) . With respect to the all concentrations , temperature exchanges lines are 
shown in the figures between 5.4 and 5.6. Also all graphics are shown in Appendix A 
separately. 
In all experiments, it is desired to observe a minimum temperature exchange, because 
in CXL treatment even though 1 or 2 ºC increase can cause a chemical burn through 
cornea. The protein structure of cornea can be damaged by these chemical burns and 
it may cause cataract.  
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Figure 5.4: The all termal experimental results for 24 ºC. 
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In Figure 5.4, investigation of the thermal stability has seen within respectively; 
Sol 3; the low concentration, Sol 4 ; all concentrations, Sol 5; the critical concentration 
till to 800 seconds of the reaction, Sol 6; all concentrations, Sol 7 ; the critical and the 
high concentrations, Sol 9; the critical and the high concentrations. Secondly, some of 
the solutions have variable decreases; Sol 1; the critical concentration has 1.5ºC, Sol 
2; the high concentration has 2ºC and the low concentration has 3,5 ºC, Sol 3; the high 
concentration has less than 1.5 ºC and the critical concentration has less than 3.5 ºC, 
Sol 5; has the critical concentration has 0.5 ºC increase , Sol 7; the low concentration 
has 0.5 ºC and the high concentration has 1.5 ºC. Furthermore some solutions show 
againn variable increases; Sol 1; the high concentration has 2 ºC and the low 
concentration has 1 ºC, Sol 2; the critical concentration has 1 ºC, Sol 5 ; the high 
concentration has 2.5 ºC. Moreover at the begining of the first 100 ms of the reactions 
Sol 7 and Sol 9 has the low concentrations increasing  nearly 3 ºC and then all staying 
stable at 24 ºC but even 1 ºC increase can cause the burn rapidly so these values are 
better to eliminated. 
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Figure 5.5: The all termal experimental results for 34 ºC. 
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In Figure 5.5, investigation of the thermal stability has seen within respectively; 
Sol 3; the critical concentration, Sol 5; all concentrations, Sol 6; the critical 
concentration, Sol 8; the high and the low concentrations, Sol 9; the all concentrations. 
Also some solutions show variable increases. Sol 1; the high and the low 
concentrations have 1 ºC, Sol 2; all concentrations have more than 2 ºC, so Sol 2 can 
be eliminated directly. Sol 3; the high and the low concentration have more then 2 ºC, 
again Sol 3 can be eliminated. Sol 4; all concentrations have nearly 0.5 ºC, Sol 6; the 
low concentration have nearly 1 ºC and the high concentration have 1 ºC increase and 
then it stays stable at 34 ºC. Sol 7; the high and the low concentrations have 1 ºC and 
the the critical concentration has 2.5 ºC, Sol 8; the critical concentration has 1 ºC. 
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Figure 5.6: The all termal experimental results for 41 ºC. 
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In Figure 5.6, investigation of the thermal stability has seen within respectively; 
Sol 1, Sol 4, Sol 5, Sol 6, Sol 8; all concentrations, Sol 7; the high and the ctirical 
concentrations. Moreover some solutions show variable increases. Sol 2; the low 
concentration has 1 ºC, the low and the high concentrations have more than 2 ºC, Sol 
3; all concentrations have more than 2 ºC, Sol 7; the low concentration has 1.5 ºC, Sol 
9 ; the low concentration has more than 2 ºC. Also in Sol 9, the high and the low 
concentrations show an obvious decrease at the first 400 s of the reaction and then they 
increase to 41 ºC again and stay stable. 
 
5.2 pH Level 
Investigation of  pH level is the second important parameter carried in this master 
thesis for the CXL treatment. Importance of the pH level is about possible chemical 
burns occuring in the cornea during CXL. Not only UV-A burns occur but also the 
solutions which has a unproper pH level  may cause a chemical burn on the cornea. In 
this master thesis there are several solutions are prepared with different chemicals 
which have less or over pH level than the corneal tolerance limits, so to determine a 
better solution is not possible unless checking of the solutions’ pH. 
5.2.1 Cornea' s  pH level tolerance and importance of pH exchanges in the eye 
Eye has a neutral pH level of 7.44 ±0.22 nearly. Cornea naturally can tolerate pH 
exchanges between 3-10  without harmful damages[69]. In Figure 5.7 pH scale is seen. 
 
Figure 5.7: pH scale. 
Chemical injuries may cause several permanent damages in the ocular surface and the 
structures of eye around the cornea. Chemical burns are referring alkali and acidic 
burns occuring on the ocular surface. Accurding to the pH tolerance limits of the 
cornea ,under 3 there can occur acidic burns and above 10 , alkali ones are seen. Alkali 
burns are more dangerous because they have lipophilic agents which have the ability 
of penetrating tissues rapidly than acidic ones. The agents effects all fatty acids of cell 
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membranes so the corneal stroma, destroy proteoglycan  ground substance and 
collagen bundles.  Acids are generally less harmful than alkali substances. They cause 
damage by denaturing and precipitating proteins in the tissues they contact. 
The  coagulated  proteins act as a barrier to prevent further penetration. The appearance 
of damaged eyes because of acidic and alkaline burns are shown in Figure 5.8. 
 
 
Figure 5.8: acid and alkaline burns 
A-B ; less harmfull acid burns 
C-D; harmful alkaline burns  
 
 
5.2.2 Mechanism of pH level measurements 
pH level measurements mechanism is the combination of  a HI 2221 Calibration Check 
pH/ORP Meter  from Hanna Instruments and a computer. The pH meter is connected 
to computer with a USB cable and it has an adjustable handle carrying the tip which 
measures the pH level of the solutions. In Figure 5.9 the instrument is shown below. 
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Figure 5.9: The pH meter. 
 
Respectively before and after exposure of UV-A light to the solutions, the tip of the 
mechanism is plunged into the cuvette and the value of the pH is read from the screen 
of the instrument. All pH datas are saved by hand or by the help of the HI 92000-5.0.20  
programme. 
5.2.3 Exchange of the  pH level for the solutions 
Before and after UV exposure  at 365 nm, pH values of all alternative solutions are 
given in Table 5.1. 
Table 5.1: The exchange of pH level of the solutions before and after UV-A exposure. 
Solution Before UV-A After UV-A 
1 8,44 7,33 
2 8,43 8,67 
3 7,49 8,04 
4 7,43 7,44 
5 7,27 7,22 
6 7,47 7,39 
7 3,22 3,26 
8 3,21 3,18 
9 2,44 3,24 
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There is no sharp distinction between pH values before and after UV-A exposure as 
can be seen from the above table. Sol7 -8 and 9 are more acidic than the other solutions 
,so they are not suitable because of the biological reason. 
 
5.3 Diffusion Coefficient 
In this section , the diffusion coefficients of the solutions are researched. It is thought 
to be the third important parameter about the CXL in this master thesis. If the solutions’ 
diffusion coefficents are enough great, then the penetration of the solutions with cornea 
is resulted more succesful.  
 
5.3.1 Fick’s Second Diffusion Law 
Diffusion or mass transport in atomic way is a result of the constant thermal motion of 
atoms, moleculs and particles that moving randomly from high concentrations to low 
in an area. Diffusion coefficient is the criterion of the diffusion mechanism. In one 
dimension the first and second laws of Fick explain the exchange of transported 
amount of the mass with respect to time and position with the equations: 
                                                                (5.1)
              
                                                                                                             (5.2) 
 
 
 
 
 
                                                
 
 
 
 
 
Figure 5.10: The diffused molecules in a cross section of solution. 
  𝘑 = −𝐷
𝑑𝐶
𝑑𝑥
 
   
𝑑𝐶𝐴
𝑑𝑡
= 𝐷
𝑑2𝐶
𝑑𝑥2
 
dx 
A 
x 
y 
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In equation 5.1 and 5.2, respectively J is the flux of diffused molecules, C is 
concentration of diffusied solution and A is the cross section of the box filled with the 
solution. 
Both of the two equations can be combined with the equation: 
                                                                                                             (5.3) 
 
The equation 5.3 has the constant diffusion coefficient. The solution of equation 5.4 is 
proposed by Nicholas A.Peppas and Steven R.Lustig includes the Bessel functions and 
series expansion with respect to the boundary conditions mentioned in the below: 
t=0             -𝑑/2< x<+𝑑/2     c=c0=0 
                                       t>0               x=±𝑑/2             c=c1 
By the help of bundary conditions the relationship between the time-dependent 
diffusion coefficient (D), the layer thickness (α) and the transported amount of the 
mass (M) are explained with the equation 5.4; 
                                                                                                             (5.4)     
Here   
𝑀𝑡
𝑀∞
 is the ratio of the mass with respect to any t to the mass of the equlibrium 
situation[70][71][72]. 
With the short time approach the equation 5.4 can be shorten like ; 
𝑀𝑡
𝑀∞
= 4√
𝐷𝑡
𝜋𝛼2
                                                            (5.5)                                                            
In this master thesis  the ratio of  
𝑀𝑡
𝑀∞
  is proportional with 
𝐼𝑡
𝐼∞
 . Diffusion coefficient 
(D) is calculated by the help of absorbed and emitted light intensities (I:absorbed and 
Is: emitted) through the quartz cuvette. α is the path light takes through the cuvette and 
its value is 1 cm. 
𝑑𝐶𝐴
𝑑𝑥
=
𝜕
𝜕𝑥
[𝐷(𝐶𝐴)
𝜕𝐶𝐴
𝜕𝑥
]   
𝑀𝑡
𝑀∞
= 1 − ∑
8
(2𝑛 + 1)2𝜋2
∞
𝑛=0
exp (−
(2𝑛 + 1)2𝜋2𝐷2
𝛼2
𝑡 ) 
 42 
                                𝐷 = 2(
𝐼
𝐼𝑠
√𝑡
1
2⁄
)2
𝜋𝛼2
4
                                                     (5.6)                                   
 
 
5.3.2 Time-drive measurements 
The mechanism for the calculation of diffusion coefficients of the solutions in this 
master thesis, the same experimental setup is used with an extra computer programme 
called OOIBase 32 in chapter 5 section 1.1. The absorbation wavelength for all of the 
solutions is 365 nm (Adopted from Acar et al, 2011). The handmade UV-aborbance 
spectrometer is connected to the computer with a usb cable. After  placing the quartz 
cuvette with solution into the rectangular space in the spectrometer, the emitted 
wavelength is set on the program.The solutions take different emission wavelengths 
between a range of 550 and 565 nm (Adopted from Acar et al ,2011).  Then the cover 
of the spectrometer is closed and during 30 minutes the life-time measurements of the 
solutions are taken. During life-time measurements the emitted light passes through 
the cuvette and reacts with the solution. Because of the reaction , the expected 
behaviour of light intensity is going down during 30 minutes. The slope of the time-
drive graphics are used in the equation 5.6 to determine the diffusion coefficients for 
all solutions. All time-drive graphics for solutions are shown in the Appendix B. 
Diffusion coefficients of the solutions used in the CXL are determined from these 
graphics after the fitting processes via Fick’s Second Law. For all solutions, the slope 
and the diffusion coefficient values  are given in the Table 5.2.  
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Table 5.2: The diffusion coefficents of the solutions. 
 
Solution        Slope Diffusion 
Coefficient(cm2/s) 
1 7,31.10⁻⁶ 
 
4,12.10⁻³ 
 
2 13,387.10⁻⁸ 
 
1,41. 10⁻² 
 
3 16,555.10⁻⁸ 
 
2,15.10⁻² 
 
4 69,29.10⁻⁷ 
 
3,7.10⁻³ 
 
5 2,8.10⁻⁶ 
 
5,72.10¯⁶ 
 
6 51,55.10⁻⁸ 
 
1,9.10⁻⁶ 
 
7 11,967.10⁻⁸ 
 
1,12.10⁻² 
 
8 13,24.10⁻⁷ 
 
1,3.10⁻⁴ 
 
9 37,69.10⁻⁷ 
 
1,1.10⁻³ 
The treatment solution Sol5 and Sol6 have smallest diffusion coefficients and Sol 7 
and Sol 2 have the biggest diffusion coefficients as can be seen from the Table 5.2. 
The diffecence between the degrees of diffusion coefficents are caused mostly by the 
exchanging of the light exposure through solutions’s molecules. So it makes out the 
changing of the amount of UV absorbance by the solutions.  Moreover the size of te 
molecules and the asymmetric linking of carbon atoms during creating chemical 
bonds. 
 5.4 Viscosity 
Viscosity is the measure of a substance's resistance to motion under an applied 
force. Knowing the viscosity of a material also affects how the production and 
transportation processes are designed. The formula for measuring viscosity is simple:   
Viscosity= 
Shear Stress
Shear Rate
                                   (5.7) 
The result is typically expressed in centipoise (cP), which is the equivilant of 1 mPa 
s (millipascal second).  
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1 cP = 0.01 poise = 0.01 gram per cm second = 0.001 Pascal second = 1 milliPascal 
second = 0.001 N s/m2. 
Shear stress is the force per unit area required to move one layer of fluid in relation 
to another.  To calculate the shear stress is the applied force (F) divided by the cross-
sectional area of material with area parallel to the applied force vector (A). The 
sembola of it is τ and the unit is  
𝑁
𝑚2
 . 
 
Figure 5.11: Shear Stress derivation. 
Shear rate is the measure of the change in speed at which intermediate layers move 
with respect to one another. The shear rate is calculated by division of the velocity of 
the moving plate, measured in meters per second with the distance between the two 
parallel plates, measured in meters. The sembola of shear rate is ?̇? and the unit is  
1
𝑠
. 
At a given temperature and shear stress, the viscosity of a fluid would remain constant 
regardless of changes to the shear rate. That fluids are called like Newtonian fluids. 
Honey and water are two examples of Newtonian fluids. However most fluids have 
viscosity that fluctuate depending on the shear rate. These fluids are called Non-
Newtonian fluids. There are five types of non-Newtonian fluids: thixotropic, 
rheopectic, pseudoplastic, dilatant, and plastic.  
There are two related measures of fluid viscosity; 
dynamic (or absolute) 
kinematic 
The Dynamic Viscosity 
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Absolute viscosity - coefficient of absolute viscosity - is a measure of internal 
resistance. Dynamic (absolute) viscosity is the tangential force per unit area required 
to move one horizontal plane with respect to an other plane - at an unit velocity - when 
maintaining an unit distance apart in the fluid. The derivation of dynamic viscosity can 
be seen in Figure 5.12. 
 
Figure 5.12: The derivation of dynamic viscosity. 
The dynamic viscosity can be expressed like in the below; 
      𝜏 = 𝜇
𝑑𝑐
𝑑𝑦
                                                     (5.8) 
In the equation 5.8, 𝑑𝑐; unit velocity (m/s), 𝑑𝑦; unit distance between layers (m) 
and 𝜇 is the dynamic viscosity having the unit Ns/m2. 
In the SI system the dynamic viscosity units are N s/m2, Pa s or kg/ (m s) - where 
1 Pa s = 1 N s/m2 = 1 kg/(m s) 
Kinematic Viscosity 
Kinematic viscosity is the ratio of - absolute (or dynamic) viscosity to density - a 
quantity in which no force is involved. Kinematic viscosity can be obtained by dividing 
the absolute viscosity of a fluid with the fluid mass density. 
The kinematic viscosity can be expressed like in the below; 
                                                  𝑣 =
𝜇
𝜌
                                                                     (5.9)  
Here 𝑣 is the kinematic viscosity that having the unit m2/s and  𝜌  is the density having 
the unit kg/m3. 
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In the SI-system the theoretical unit of kinematic viscosity is m2/s - or Stoke (St) where 
1 St (Stokes) = 10-4 m2/s = 1 cm2/s. 
Since the Stoke is a large unit it is often divided by 100 into the smaller unit Centistoke 
(cSt) – where 1 St = 100 cSt. 
5.4.1 Mechanism of viscosity measurements 
 
The viscosity measurements of the all solutions are done with a Rheometer labeled 
Brookfield, model of LV-DVIII  at the Rheological Measurements & Nanocomposite 
Production and Research Laboratory in Physics Deparment. The rheometer is 
connected to computer with a USB cable and the all datas are taken with the 
programme named Rheocalc V2.3.  The rheometer in experimens is seen in Figure 
5.13. 
 
Figure 5.13: Rheometer. 
The principle of operation of the DV-III is to drive a spindle (which is immersed in 
the test fluid) through a calibrated spring. The viscous drag of the fluid against the 
spindle is measured by the spring deflection. Spring deflection is measured with a 
rotary transducer. The measuring range of a DV-III (in centipoise) is determined by 
the rotational speed of the spindle, the size and shape of the spindle, the container the 
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spindle is rotating in, and the full scale torque of the calibrated spring. In Figure 5.14 
there can be seen the spindle of the rheometer. 
 
Figure 5.14: The spindle of the rheometer. 
5.4.2 The viscosity values for the solutions 
According to the shear stress exchanges with respest to shear rate , it can be understood 
that a solutions is Newtonian or Non-Newtonian. Fluid’s flow behaviours are 
explained with Power-Law generally for non-Newtonian fluids. This law is defined as; 
                                                                                                  (5.10) 
Here τ is Shear Stress κ is a material-based constant , n is Power-Law index and γ ̇ is 
the applied shear rate. Fluids can be defined as two basic type. Newtonian fluids shows 
a linear line where Non-Newtonians have increasing or decreasing lines. The types of 
fluid according t the viscosity is seen in Figure 5.15. 
τ = κγ ̇n 
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Figure 5.15: The types of fluid according to the viscosity 
 
 
To determine the type of measurement system for the solutions, firstly Sol 3 was 
prepared and tried in the Rheometer exemplary. In Figure 5.16 the graphic of Shear 
Stress with respect to Shear Rate measurements for Sol 3 is shown.  
     
 
 
Figure 5.16: Shear Stress vs Shear Rate measurements for Sol 3. 
 
 
Both of two materials’ hysteresis curves; because of  the loading  and the unloading 
curves’ initial and final points overlapping and being independent of time, show an 
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elastic change in their shapes with an internal friction. Also having an infinitesimal 
small area between the loading  and unloading curves indicate that there is no energy 
loss. 
Before the UV, the Sol 3 showed Dilatant (shear thickening) flow behaviour. In this 
type of flow, the very act of deforming a material can cause a rearrangement of its 
microstructure such that the resistance to flow increases with any increase in shear 
rate. In other words, the viscosity increases with applied shear rate and the flow curve 
can be fitted with the power law shown in the equation 5.10  where n>1. In this type 
of fluids , the increase of the deformation velocity cause the increase of the viscosity. 
In the solutions that show dilatant flow behaviour, particules placed tightly to the void 
space between molecules (Figure 5.17). The minimum void space between molecules 
inceases with shear rate increments.  Although there is sufficient carrier quantity to fill 
this void space in suspensions, if it is not sufficient to fill the void space lower shear 
rates and the molecules are not wetted by suspension agents, the suspension takes a 
hard viscosity form. If the slip velocity increases the resistance to flow increases too.   
 
Figure 5.17: Dilatant flow mechanism. 
After the UV treatment, the flow types chaged and turn into the Newtonian Flow which 
indicates that η is independent of the applied shear rate.  
The UV treatment changes the flow types due to the structural changes of the material. 
Interaction of microstructure decreased with UV treatment. Because of the different 
flow regimes, the apparent viscosity values at different speeds were used to determine 
the correlation between the solutions. Viscosity values of the solutions are given in 
Table 5.3 for some determined speed with respect to hysteresis. 
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Table 5.3: Viscosity values for the solutions 
c(r.p.m) 
 
50 50 120 120 200 200 250 250 
η(Pa.s) 
 uv 
before 
uv 
after 
uv 
before 
uv 
after 
uv 
before 
uv 
after 
uv 
before 
uv 
after 
Sol1 
 
0,987 2,375 1,099 1,272 1,117 1,208 1,418 1,407 
Sol2 
 
1,560 1,170 1,235 1,079 1,209 1,109 1,389 1,389 
Sol3 
 
1,275 1,221 1,202 1,105 1,135 1,123 1,460 1,392 
Sol4 
 
55,062 54,804 27,494 27,494 16,496 16,496 13,197 13,197 
Sol5 
 
37,771 35,743 27,494 27,494 16,496 -- 13,197 -- 
Sol6 
 
62,924 59,750 27,494 27,494 16,496 16,496 13,197 13,197 
Sol7 
 
2,019 0,972 1,808 1,265 1,732 1,263 1,722 1,412 
Sol8 
 
1,992 2,190 1,935 1,766 1,857 1,670 1,874 1,725 
Sol9 
 
1,863 1,251 1,666 1,398 1,619 1,385 1,587 1,454 
       (c: motor speed, η: apparent viscosity) 
  
The table below show the all viscosity values for solutions.  At 200 r.p.m and 250 
r.p.m Sol 5’s viscosity is not shown because of being out of range, it could not be 
measured.  
Measurements are done before UV treatment and after UV treatment to see how the 
exposure of light changes elastcity of solutions. 
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6. CONCLUSIONS AND RECOMMENDATIONS 
6.1 Experimental Thermal Effect Comments 
As  mentioned before in chapter 5 section 1.2 , figure 5.31, the most preferable solution 
should have a temperature stability. Furthermore maybe one or 2º C decrease may be 
acceptable against any sudden temperature increases. 
24°C 
The most propers are Sol 4, Sol 6; because of having all concentrations stable. 
Second degrees are Sol 3; low concentration, Sol 5; the critical concentration, Sol 7; 
the critical and the high concentrations, Sol 9 the critical and the high concentrations. 
Third degrees are acceptable because of having 0.5 to 2 º C decreases, these are Sol 1; 
the critical, Sol 2 and Sol 3 the high concentrations, Sol 5; the low concentration and 
finally Sol 7; the low and the high concentrations. 
34° C 
The most propers are Sol 5, Sol 9 because of having all concentrations stable. Second 
degrees are Sol 3 and Sol 6 only the critical one, Sol 8; the high and the low 
concentrations. 
41°C 
The most propers are Sol 1, Sol 4, Sol 5, Sol 6, Sol 8. Second degrees are Sol 7; the 
high and the critical concentrations. Also Sol 9; the high and the critical concentrations 
also show thermal stability after having decreasing in the first 400 seconds of the 
reaction. 
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                       Figure 6.1: Temperature exchange at 34 °C for Sol 6. 
According to the Figure 6.1, both concentrations do not show any temperature 
increase or decrease. So, temperature stability is a proper condition in CXL. This 
means Dextrin and glucose could be suggested as alternatives to Dextran and Saline 
Solution in current treatment. Other temperature exchanges are shown in Appendix 
A.  
6.2 pH Level and Diffusion Coefficient Comments 
The pH level measurements of the both solutions are fitted the range of cornea’s 
naturel pH tolerance limits. Only the solution 9 has a low pH than 3 so out of the 
tolerance before UV treatment. Although these results let the solutions to be useful for 
CXL treatment, the solutions which have the border value for pH for example near 3  
or near 10 could be eliminated to have a safer result. So Solutions 7, 8 and 9 are 
eliminated because of the pH levels before and after UV. Sol 6 has pH value 7,47 
before UV and has pH value 7,39 after UV. UV exposure did not effect pH exchange, 
also it is in the cornea’s naturel pH tolerance. So Sol 6 does no show any danger about 
causing chemical burns through cornea.  
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Solutions can be ordered as D7>D2> D3> D9> D4> D1> D8> D6> D5  about their 
diffusion coefficients.  The greater diffusion coefficients are acceptable than the others 
because, if any solutions have a greater diffusion coefficient, it can provide a better 
penetration of solution through cornea.  
 
6.3 Viscosity Comments  
 
All solutions’ viscosity values in this master thesis were investigated to being 
Newtonian or Non-Newtonian fluid. In figure 5.28 the type of fluid with respect to 
their viscosity are shown. According to the experimental results ,solutions showed 
mostly Dilatant or Pesudoplastic fluid types. If n constant (the slope value in the 
graphics) is greater than 1 , the fluid is called as Dilatant. In these experiments , 
respectively Sol 1 before UV, Sol 2 after UV, Sol 7 after UV and Sol 9 after UV are 
Dilatants. If n constant is lower than 1, the fluid is called as Pseudoplastic.  Sol 2 before 
UV, Sol 4 before and after UV, Sol 5 before and after UV, Sol 6 before and after UV, 
Sol 7 before UV , Sol 8 before and after UV and Sol 9 before and after UV are 
Pseudoplastics. Sol 3 as mentioned in chapter 5 section 4.2; before UV treatment has 
Dilatant model and after UV treatment, it turns to Newtonian model. Moreover Sol 1 
after UV showed nearly as Herschel-Bulkley General Model. In this model the 
solutions fit the equations below: 
 (6.1) 
 
According to the Figure  6.2.a and 6.2.b , before and after UV treatment, Sol 6  
show Pseudoplastic flow behaviour with respect to viscosity. In this type of model, 
solutions fit the equation 5.10   where n < 1. Before UV exposure, Sol 6 has κ ; the 
material base constant 3,539 and n; power-law index 0,045. After UV exposure, Sol 6 
has κ ;the material base constant 3,146 and n ; power-law index is 0,125. 
  
 
 
 
 
𝑙𝑛𝜏 = 𝑙𝑛𝜏0 + 𝑘 ?̇?
𝑛  
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Figure 6.2.a: Modelling of  flow curve for Sol 6 before UV. 
 
Figure 6.2.b: Modelling of  flow curve for Sol 6 after UV. 
 
The modelling of the flow curves for the solutions are given in the Table 6.1. 
Also all solutions’ flow curves are shown in Appendix C. 
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Table 6.1: The modelling of the flow curves for the solutions. 
Solution 
Model 
Sol1 (before UV) τ = −5.389γ ̇1.177 
 
Power Law 
Dilatant 
Sol1 (after UV) 𝑙𝑛𝜏 = 0.387 + 3.436 10−5 ?̇?1.797  
 
Herschel-
Bulkley 
Dilatant 
Sol2 (before UV) τ = −3.763γ ̇0.893 
 
Power Law 
Pseudoplastic 
Sol2 (after UV) τ = −4.748γ ̇1.059 
 
Power Law 
Dilatant 
Sol3 (before UV) 𝑙𝑛𝜏 = −1.672 + 0.453 ?̇?0.334  
 
Herschel-
Bulkley 
Pseudoplastic 
Sol3 (after UV) τ = 0.126 + 0.028γ ̇  
 
Bingham 
Newtonian 
Newtonian 
Sol4 (before UV) τ = 2.733γ ̇0.204 
 
Power Law 
Pseudoplastic 
Sol4 (after UV) τ = 2.733γ ̇0.204 
 
Power Law 
Pseudoplastic 
Sol5 (before UV) τ = 0.523γ ̇0.643 
 
Power Law 
Pseudoplastic 
Sol5 (after UV) τ = 0.222γ ̇0.701 
 
Power Law 
Pseudoplastic 
Sol6 (before UV) τ = 3.539γ ̇0.045 
 
Power Law 
Pseudoplastic 
Sol6 (after UV) τ = 3.146γ ̇0.125 
 
Power Law 
Pseudoplastic 
Sol7 (before UV) τ = −3.476γ ̇0.896 
 
Power Law 
Pseudoplastic 
Sol7 (after UV) τ = −5.485γ ̇1.208 
 
Power Law 
Dilatant 
Sol8 (before UV) τ = −3.741γ ̇0.957 
 
Power Law 
Pseudoplastic 
Sol8 (after UV) τ = −3.16γ ̇0.836 
 
Power Law 
Pseudoplastic 
Sol9 (before UV) τ = −3.567γ ̇0.899 
 
Power Law 
Pseudoplastic 
Sol9 (after UV) τ = −4.825γ ̇1.102 
 
Power Law 
Dilatant 
 
 
6.4 The Most Proper Alternative Solution 
 
After comparing all physical parameters, the solutions are eliminated according to the 
unacceptible results. Comparing both of the concentrations , if any of them don’t show 
a stable curve, it is enough to accept the critical one’s stability. Moreover  the most 
acceptible temperature is 34 ºC which is the cornea’s naturel temperature. In table 6.2 
the value of the acceptable temperature exchanges for the solutions are shown. 
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According to the cornea’s naturel pH tolerance range, the most acceptable values are 
signed. Diffusion coefficients are ordered from biggest to smallest. If the solution has 
a small viscosity, there can be seen a better penetration through cornea, so Newtonian 
and  Pseudoplastic materials are more preferable than the Dilatant materials. After all 
comparison, the most biocompatiable features are shown with smiling face and the 
other ones are shown with a cross in Table 6.2. Finally, the  solution 3 is first 
alternative to the treatment solution 5. Moreover Sol 6 also can be another alternative 
to the thin corneas in CXL treatment due to the small diffusion coefficient. 
 
Table 6.2: The all comparisons for the solutions. 
 
Sol 1 
Temperature:41 
pH: 
Diffusion coefficient:6 
Viscosity:  
 
Sol 2  
Temperature:24 
pH:  
Diffusion coefficient:2 
Viscosity:  
 
Sol 3 
Temperature:34  
pH:  
Diffusion coefficient:3 
Viscosity:  
 
Sol 4 
Temperature:41 
pH:  
Diffusion coefficient:5 
Viscosity:  
 
Sol 5 
Temperature:34 
pH:  
Diffusion coefficient:9 
Viscosity:  
 
Sol 6 
Temperature:24,34,41 
pH:  
Diffusion coefficient:8 
Viscosity:  
 
Sol 7 
Temperature:41 
pH: 
Diffusion coefficient:1 
Viscosity:   
 
Sol 8 
Temperature:41 
pH:  
Diffusion coefficient:7 
Viscosity:  
 
Sol 9 
Temperature:34 
pH:  
Diffusion coefficient:4 
Viscosity:  
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Appendix A 
Temperature measurements for the solutions with three  different initial temperature 
degrees  24, 34 and 41  C can be seen from Figures 1 to 27. 
Temperature exchange at 24ºC for solutions without Dextran and Dextrin 
 
 
                         Figure 1: Temperature exchange at 24ºC for Sol1 
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                         Figure 2: Temperature exchange at 24º C for Sol2 
 
                        Figure 3: Temperature exchange at 24ºC for Sol3 
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Temperature exchange at 24ºC for solutions with Dextran 
 
 
                         Figure 4: Temperature exchange at 24ºC for Sol4 
 
 
                        Figure 5: Temperature exchange at 24ºC for Sol5 
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                        Figure 6: Temperature exchange at 24ºC for Sol6 
             
 
 
Temperature exchange at 24ºC for solutions with Dextrin 
 
                         Figure 7: Temperature exchange at 24º C for Sol7 
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                        Figure 8: Temperature exchange at 24 C for Sol8 
 
                         Figure 9: Temperature exchange at 24ºC for Sol9 
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Temperature exchange at 34ºC for solutions without Dextran and Dextrin 
 
                        Figure 10: Temperature exchange at 34ºC for Sol1 
 
 
                          Figure 11: Temperature exchange at 34ºC for Sol2 
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                       Figure 12: Temperature exchange at 34ºC for Sol3 
 
 
 
Temperature exchange at 34ºC for solutions with Dextran 
 
                         Figure 13: Temperature exchange at 34ºC for Sol4 
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                       Figure 14: Temperature exchange at 34ºC for Sol5 
 
 
                        Figure 15: Temperature exchange at 34ºC for Sol6 
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Temperature exchange at 34ºC for solutions with Dextrin 
Figure 16: Temperature exchange at 34ºC for Sol7 
 
                        Figure 17: Temperature exchange at 34ºC for Sol8 
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                      Figure 18: Temperature exchange at 34ºC for Sol9 
 
 
Temperature exchange at 41ºC for solutions without Dextran and Dextrin 
 
                        Figure 19: Temperature exchange at 41ºC for Sol1 
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                        Figure 20: Temperature exchange at 41ºC for Sol2 
 
 
                        Figure 21: Temperature exchange at 41ºC for Sol3 
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                        Figure 22: Temperature exchange at 41ºC for Sol4 
 
 
 
 
                        Figure 23: Temperature exchange at 41ºC for Sol5 
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                       Figure 24: Temperature exchange at 41ºC for Sol6 
 
                      Figure 25: Temperature exchange at 41ºC for Sol7 
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                       Figure 26: Temperature exchange at 41ºC for Sol8 
 
 
 
 
                         Figure 27: Temperature exchange at 41ºC for Sol9 
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Appendix B 
Time –drive measurements are shown for 9 solutions between Figures 1 to 9. After the 
fitting process, the slope values of the curves which are used to determine the diffusion 
coefficients can be seen from the tables on the graphics. 
 
 
Figure 1: Time-drive measurement for Sol 1. 
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Figure 2: Time-drive measurement for Sol 2. 
 
 
Figure 3:Time-drive measurement for Sol3. 
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Figure 4:Time-drive measurement for Sol4. 
 
Figure 5: Time-drive measurement for Sol 5. 
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Figure 6:Time-drive measurement for Sol6. 
 
 
 
Figure 7:Time-drive measurement for Sol7. 
 
 81 
 
Figure 8:Time-drive measurement for Sol8. 
 
 
Figure 9:Time-drive measurement for Sol9. 
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Appendix C 
The modelling of the flow curves for the solutions are shown between Figure 1 t 10. 
 
 
Figure 1:Modelling of  flow curves for Sol 1. 
 
 
Figure 2: Modelling of  flow curves for Sol 2. 
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Figure 4: The linear fit of Shear Stress vs Shear Rate curve for Sol 3 before 
and after UV treatment. 
 
  
Figure 3: The exponantiel fit of Shear Stress vs Shear Rate curve for Sol 3 before 
and after UV treatment. 
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Figure 5.a: Modelling of  flow curve for Sol 4 before UV. 
 
 
Figure 5.b: Modelling of  flow curve for Sol 4 after UV. 
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Figure 6.a: Modelling of  flow curve for Sol 5 before UV. 
 
 
Figure 6.b: Modelling of  flow curve for Sol 5 before UV. 
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Figure 7.a: Modelling of  flow curve for Sol 6 before UV. 
 
 
Figure 7.b: Modelling of  flow curve for Sol 6 after UV. 
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Figure 8: Modelling of  flow curve for Sol 7. 
 
 
Figure 9: Modelling of  flow curve for Sol 8. 
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Figure 10: Modelling of  flow curve for Sol 9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 89 
 
CURRICULUM VITAE 
 
 
Name : Hilal 
Surname : ÖZDEMİR 
Birth place and date : İstanbul/ Kadıköy  20.11.1987 
E-mail : hilalozdemir_9@hotmail.com  
 
Undergraduate : Kocaeli University 
                                        Physics   Department 
 
Graduate : ITU Physics Engineering  
 
 
 
